Our Pricing

What Is Mounjaro and How Can Patients in Peebles Access It?

Published: 4 October 2026

Mounjaro Peebles residents can now access through Cured Pharmacy, a fully UK-registered online service offering tirzepatide weight loss injections from £124.99 with free clinical assessment and discreet delivery across Scotland. Mounjaro (tirzepatide) is a once-weekly GLP-1 receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with weight-related comorbidities, demonstrating average weight reductions of 15-22.5% in the SURMOUNT clinical trials [1]. Patients in Peebles no longer need to travel to access specialist weight management prescriptions, as our UK-registered clinical team provides remote consultations and next-day delivery throughout the Scottish Borders.

How Does Mounjaro Work for Peebles Patients Seeking Weight Loss?

Mounjaro Peebles patients receive contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist that regulates appetite, slows gastric emptying, and improves glycaemic control [2]. This dual-action mechanism distinguishes tirzepatide from single-pathway GLP-1 agonists like semaglutide, offering enhanced weight loss outcomes in head-to-head trials. In the SURMOUNT-1 trial, participants without diabetes achieved mean weight reductions of 15.0% (5mg), 19.5% (10mg), and 20.9% (15mg) over 72 weeks compared to 3.1% with placebo [1].

The medication works by mimicking natural incretin hormones that signal satiety to the brain, reducing hunger between meals and decreasing overall caloric intake. Patients typically start on a 2.5mg dose for four weeks to minimise gastrointestinal side effects, then escalate every four weeks through 5mg, 7.5mg, 10mg, 12.5mg, to a maximum maintenance dose of 15mg based on individual tolerance and weight loss response [3]. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every Peebles patient receives personalised dosing guidance during their clinical assessment.

Mounjaro Peebles Pricing and How to Order from Cured Pharmacy

Mounjaro Peebles pricing at Cured Pharmacy starts from £124.99 per four-week supply, with transparent costs displayed before consultation—no hidden fees or surprise charges. New patients receive £20 off their first order using code Weightlossnew, bringing the initial month to £124.99. Unlike high-street pharmacies that may require multiple in-person appointments, our streamlined online service completes clinical assessments in under three minutes, with prescriptions issued the same day by UK-registered prescribers.

Ordering is straightforward: complete the free online consultation questionnaire covering medical history, current medications, and weight management goals. Our clinical team reviews your submission within hours, and if approved, your prescription is dispensed from our GPhC-registered pharmacy (9012511) and shipped via Royal Mail Tracked 24 or DPD next-day delivery in 100% discreet packaging. Peebles patients typically receive their first supply within 24-48 hours of approval, with automatic reminders for refills to ensure treatment continuity.

Subscription Options for Mounjaro Peebles Residents

We offer flexible subscription plans that automatically deliver Mounjaro to Peebles addresses every 28 days, ensuring you never miss a dose during your weight management programme. Subscriptions can be paused, modified, or cancelled at any time through your online account, with no long-term commitments or cancellation fees. This convenience is particularly valuable for patients in rural Scottish Borders communities where pharmacy access may be limited.

Clinical Eligibility for Mounjaro Peebles Prescriptions

Mounjaro Peebles prescriptions are issued only to clinically eligible adults meeting MHRA-approved criteria: BMI ≥30 kg/m², or BMI ≥27 kg/m² with at least one weight-related comorbidity such as type 2 diabetes, hypertension, dyslipidaemia, or obstructive sleep apnoea [4]. Patients must be 18 years or older, not pregnant or breastfeeding, and have no contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

During your clinical assessment, our prescribers evaluate previous weight loss attempts, current medications that may interact with tirzepatide (such as insulin or sulfonylureas), and any history of pancreatitis, severe gastrointestinal disease, or diabetic retinopathy. Mounjaro is not suitable for patients with type 1 diabetes or those seeking purely cosmetic weight reduction below clinical BMI thresholds. All prescribing decisions are made by independent UK-registered clinicians following GMC and GPhC guidelines, ensuring patient safety remains paramount.

Mounjaro Peebles Suitability for Different Patient Groups

Patients in Peebles with type 2 diabetes may be particularly suitable candidates, as tirzepatide demonstrated HbA1c reductions of 1.9-2.4% alongside weight loss in the SURPASS trials [2]. However, dose adjustments to existing diabetes medications—especially insulin and sulfonylureas—are often necessary to prevent hypoglycaemia. Our clinical team coordinates with your NHS GP when appropriate to ensure safe, integrated care across your diabetes management programme.

Expected Results and Timeline for Mounjaro Peebles Users

Mounjaro Peebles patients typically observe initial weight loss within the first 4-8 weeks, with progressive reductions continuing through 60-72 weeks as doses escalate to therapeutic levels [1]. In SURMOUNT-1, 89% of participants on the 15mg dose achieved ≥5% weight loss, 55% achieved ≥20% weight loss, and some individuals lost over 25% of their starting body weight by week 72. Individual results vary based on baseline BMI, adherence to dosing schedules, dietary modifications, and physical activity levels.

Beyond the number on the scales, patients report significant improvements in weight-related comorbidities: blood pressure reductions averaging 6-8 mmHg systolic, improved lipid profiles, better glycaemic control, and enhanced mobility and quality of life [3]. Mounjaro Peebles users should combine injections with a reduced-calorie diet and increased physical activity for optimal outcomes—medication alone is not a substitute for lifestyle modification. Our clinical team provides ongoing support and monitoring throughout your treatment journey, with regular check-ins to assess progress and adjust doses as needed.

Managing Side Effects of Mounjaro in Peebles Patients

Mounjaro Peebles patients most commonly experience gastrointestinal side effects during dose escalation, including nausea (reported by 20-30% of trial participants), diarrhoea, constipation, vomiting, and abdominal discomfort [4]. These symptoms are usually mild to moderate, transient, and diminish as the body adapts to each new dose level. Starting at the lowest 2.5mg dose and escalating slowly every four weeks significantly reduces the incidence and severity of GI disturbances.

Practical management strategies include eating smaller, more frequent meals, avoiding high-fat or spicy foods, staying well-hydrated, and taking the injection on the same day each week after a light meal. If nausea persists, our clinical team may recommend remaining at your current dose for an additional four weeks before escalating, or prescribing anti-emetic medications for short-term relief. Serious but rare side effects—such as pancreatitis (severe abdominal pain radiating to the back), gallbladder disease, or allergic reactions—require immediate medical attention and discontinuation of treatment. Mounjaro Peebles prescriptions include comprehensive patient information leaflets and 24/7 access to our pharmacist support line for urgent queries.

When to Contact Your Prescriber About Mounjaro Side Effects

Contact our clinical team immediately if you experience severe, persistent abdominal pain, signs of pancreatitis, symptoms of thyroid tumours (lump in neck, hoarseness, difficulty swallowing), or signs of severe allergic reaction (rash, swelling, difficulty breathing). Regular monitoring of renal function is recommended for patients with pre-existing kidney disease, as gastrointestinal side effects can lead to dehydration and acute kidney injury if fluid intake is inadequate.

Why Choose Cured Pharmacy for Mounjaro Peebles Delivery

Cured Pharmacy serves Mounjaro Peebles patients with the lowest guaranteed UK pricing (from £124.99), transparent upfront costs, and genuinely free clinical consultations with no hidden consultation fees. As a fully GPhC-registered pharmacy (9012511) under superintendent pharmacist Tarun Kumar (GPhC 2233073), we dispense only authentic, UK-licensed Mounjaro sourced directly from licensed wholesalers—never grey-market or counterfeit products.

Our service is designed for convenience: complete your consultation online in under three minutes, receive same-day prescribing decisions, and benefit from next-day delivery across Peebles and the Scottish Borders in discreet, unmarked packaging. We provide ongoing clinical support throughout your treatment, with easy prescription refills, flexible subscription management, and direct access to our pharmacist team for dosing questions or side effect guidance. Unlike fragmented services requiring separate GP appointments, our integrated model streamlines the entire process from assessment to doorstep delivery, saving Peebles patients time and ensuring treatment continuity.

Mounjaro Peebles Patient Support and Follow-Up Care

Every Mounjaro Peebles prescription includes access to our patient support programme: monthly progress check-ins, weight tracking tools, dietary and exercise guidance, and direct messaging with our clinical team. We coordinate with your NHS GP when necessary to ensure integrated care, particularly for patients with complex medical histories or multiple prescriptions. Your safety and success are our priorities, backed by our commitment to MHRA, NICE, and GPhC standards of pharmaceutical care.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 4 October 2026]
2. Rosenstock, J., Wysham, C., Frías, J. P., et al. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 4 October 2026]
3. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. GOV.UK. [accessed 4 October 2026]
4. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating obesity [ID6180]: Final scope. NICE. [accessed 4 October 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 4 October 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 4 October 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 4 October 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.